Market Snapshot
S&P Futures
3,819
Dow Futures
30,822
Nasdaq Futures
11,785
AN2 Therapeutics, Inc. (ANTX) stock rallied over 5.90% intraday to trade at $8.80 a share on NASDAQ. The stock opened with a gain of 17.33% at $7.87 and touched an intraday high of $8.95, rising 5.90% against the last close of $8.31. The stock went to a low of $8 during the session.
Prev. Close
Market Cap
Day Low
Open
Number of Shares
Day High
P/E ratio
EPS (TTM)
Cash Flow per Share
Free Float in %
Book Value
Volume
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
2022-07-06 | $7.87 | $8.95 | $8 | $8.8 | 27,571 |
2022-07-05 | $7.5 | $8.7 | $7.49 | $8.31 | 53,200 |
2022-07-01 | $7.68 | $8.73 | $7.41 | $8.16 | 32,900 |
2022-06-30 | $7.93 | $8.2 | $6.879 | $7.75 | 48,700 |
2022-06-29 | $8 | $8.83 | $7.805 | $7.91 | 47,700 |
2022-06-28 | $8.439 | $8.95 | $8.09 | $8.14 | 69,200 |
2022-06-27 | $8.69 | $9.09 | $8.28 | $8.39 | 42,000 |
2022-06-24 | $8.65 | $9.86 | $8.41 | $8.75 | 432,900 |
2022-06-23 | $8.3 | $9.16 | $8.205 | $8.78 | 84,500 |
2022-06-22 | $8.08 | $8.59 | $7.97 | $8.12 | 61,200 |
Employees-
Beta-
Sales or Revenue0
5Y Sales Change-
Fiscal Year Ends2021-12-30
SectorHealth Care
IndustryPharmaceuticals
AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menlo Park, California.
AN2 Therapeutics, Inc. (NASDAQ: ANTX) stock price is $8.8 as of the last check on Wednesday, July 6. During the trading session, ANTX stock reached the peak price of $8.95 while $8 was the lowest point it dropped to.
The NASDAQ listed ANTX is part of Pharmaceuticals industry that operates in the broader Health Care sector. AN2 Therapeutics, Inc. , a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases.
Mr. Joseph S. Zakrzewski
Co-founder & Independent Chairman
Mr. Eric E. Easom
Co-founder, CEO, Pres & Director
Ms. Lucy O. Day CPA
CFO, Sec. & Treasurer
Dr. Paul Eckburg M.D.
Chief Medical Officer
ANTX stock traded closed the last session at $8.8, which is $0.49 or 5.90% lower than its previous close of $8.31. ANTX's current trading price is 27.93% lower than its 52-week high of $23.58 where as its distance from 52-week low of 6.88% is -62.68%.
Number of ANTX employees currently stands at -. ANTX operates from 1800 El Camino Real, Suite D, Menlo Park, CA 94027, United States.
Official Webiste of $ANTX is: https://www.an2therapeutics.com
ANTX could be contacted at ANTX operates from 1800 El Camino Real, Suite D, Menlo Park, CA 94027, United States, or at phone #650-331-9090 and can also be accessed through its website.
ANTX stock volume for the day was 27,527 shares while in the previous session number of ANTX shares traded was 27,571 . The average number of ANTX shares traded daily for last 3 months was 68.54 Thousands.
The percentage change in ANTX stock occurred in the recent session was 5.90% while the dollar amount for the price change in ANTX stock was $0.49.
In the recent session, the day high for ANTX stock was $8.95 while the low for ANTX stock touched on the day was $8.
The market value of ANTX currently stands at 162.18 Million with its latest stock price at $8.8 and 19.4 Million of its shares outstanding.